In the first undertaking toward that goal, GLP-1 was explored as an ideal pharmacological partner, leading to the purposeful discovery of the first GLP-1R/GcgR co-agonists
First, antioxidant properties allow alpha-lipoic acid to neutralize free radicals and reduce oxidative stress, which is linked to damage that can increase heart disease risk ( Second, its been shown to improve endothelial dysfunction a condition in which blood vessels cannot dilate properly, which also raises the risks of heart attack and stroke ( Whats more, a review of studies found that taking an alpha-lipoic acid supplement lowered triglyceride and LDL (bad) cholesterol levels in adults with metabolic disease ( Summary Alpha-lipoic acid has strong antioxidant properties, which may reduce inflammation and skin aging, promote healthy nerve function, lower heart disease risk factors, and slow the progression of memory loss disorders
Pottegrd A, Andersen JH, Sndergaard J, Thomsen RW, Vilsbll T (2022) Changes in the use of glucose-lowering drugs: a Danish nationwide study
( [ \- Link Opens in New Tab]( 04
The Payer Perspective: Payers, including insurers and healthcare systems, are becoming increasingly discerning when it comes to covering pharmaceutical treatments, especially for chronic conditions like obesity and diabetes
The argument that the core demand of patients is not being met is not what were convinced about, he said